LENZ Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -13.54M-69.97M-49.77M
Depreciation and Depletion 0.10M0.70M2.40M2.40M
Share-based Compensation 0.18M7.87M13.53M1.34M6.37M
Gains from Sales and Divestitures 0.55M
Gains from Investment Securities 2.80M5.00M0.20M0.19M1.38M
Asset Writedowns and Impairment 56.62M
Non-cash Items 2.33M
Cash from Operations -8.72M-52.85M-87.98M-60.38M-59.39M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.60M1.06M4.02M
Depreciation & Amortization (CF) 0.12M0.73M2.35M0.01M0.06M
Change in Working Capital
Change in Account Payables 0.59M1.82M0.19M0.86M-4.28M
Change in Accured Expenses 0.47M2.22M1.11M7.78M-7.46M
Investing Activities
Capital Expenditures 1.54M5.74M6.59M0.03M0.47M
Sales of Property, Plant and Equipment 1.90M
Change in Acquisitions & Divestments 170.25M22.50M87.90M
Cash from Investing Activities -1.54M-5.74M-241.86M-29.62M-154.48M
Financing Activities
Other financing activities 2.48M
Debt Issuance and Repayment
Long-Term Debt Issuances 5.00M
Change in Capital Stock
Shares Issued 251.32M0.66M0.20M79.51M
Preferred Shares Issued 24.82M165.52M82.98M
Misc.
Cash from Financing Activities 30.08M417.47M0.60M80.70M199.00M
Change in Cash 19.81M358.88M-329.25M-9.30M-14.87M
Free Cash Flow -10.27M-58.59M-94.57M-60.41M-59.86M
Net Cash Flow 19.81M358.88M-329.25M-9.30M-14.87M